• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Host-directed therapies and holistic care for tuberculosis.

作者信息

Zumla Alimuddin, Ippolito Giuseppe, Ntoumi Francine, Seyfert-Margolies Vicki, Nagu Tumaini J, Cirillo Daniela, Chakaya Jeremiah Muhwa, Marais Ben, Maeurer Markus

机构信息

Department of Infection, University College London, London, UK; NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.

National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.

出版信息

Lancet Respir Med. 2020 Apr;8(4):337-340. doi: 10.1016/S2213-2600(20)30078-3. Epub 2020 Feb 27.

DOI:10.1016/S2213-2600(20)30078-3
PMID:32113574
Abstract
摘要

相似文献

1
Host-directed therapies and holistic care for tuberculosis.结核病的宿主导向疗法与整体护理
Lancet Respir Med. 2020 Apr;8(4):337-340. doi: 10.1016/S2213-2600(20)30078-3. Epub 2020 Feb 27.
2
Introduction.引言。
Semin Immunol. 2014 Dec;26(6):429-30. doi: 10.1016/j.smim.2014.09.007. Epub 2014 Oct 16.
3
Back to the future: host-targeted chemotherapeutics for drug-resistant TB.
Future Microbiol. 2012 Apr;7(4):431-5. doi: 10.2217/fmb.12.19.
4
Clinical Management of Drug-resistant Mycobacterium tuberculosis Strains: Pathogen-targeted Versus Host-directed Treatment Approaches.耐药结核分枝杆菌菌株的临床管理：针对病原体与针对宿主的治疗方法
Curr Pharm Biotechnol. 2019;20(4):272-284. doi: 10.2174/1389201019666180731120544.
5
Host-directed drug therapy for tuberculosis.用于治疗结核病的宿主导向药物疗法。
Nat Chem Biol. 2015 Oct;11(10):748-51. doi: 10.1038/nchembio.1917.
6
Palliative care for drug-resistant tuberculosis: when new drugs are not enough.耐多药结核病的姑息治疗：新药不足时的应对之策
Lancet Respir Med. 2018 Apr;6(4):251-252. doi: 10.1016/S2213-2600(18)30066-3. Epub 2018 Feb 6.
7
Efficacy and safety of isoniazid preventive therapy in light of increasing multi-drug resistance in tuberculosis.鉴于结核病多重耐药性不断增加，异烟肼预防性治疗的疗效与安全性
Int J Mycobacteriol. 2015 Dec;4(4):354-5. doi: 10.1016/j.ijmyco.2015.06.001. Epub 2015 Jul 9.
8
The surprising diversity of Mycobacterium tuberculosis: change you can believe in.结核分枝杆菌惊人的多样性：你可以相信的变化。
J Infect Dis. 2012 Dec 1;206(11):1642-4. doi: 10.1093/infdis/jis603. Epub 2012 Sep 14.
9
Multidrug resistant tuberculosis: a continuing crisis.耐多药结核病：持续的危机。
Lancet Infect Dis. 2016 Dec;16(12):1337-1338. doi: 10.1016/S1473-3099(16)30479-0. Epub 2016 Nov 15.
10
Opportunities for Overcoming Drug Resistance: Emerging Mycobacterial Targets and Host-Directed Therapy.克服耐药性的机遇：新兴分枝杆菌靶点和宿主导向治疗。
Int J Mol Sci. 2019 Jun 12;20(12):2868. doi: 10.3390/ijms20122868.

引用本文的文献

1
Concerns about COVID-19 and tuberculosis in Brazil: Social and public health impacts.巴西对新冠病毒和结核病的担忧：社会与公共卫生影响
Enferm Infecc Microbiol Clin. 2021 Apr;39(4):216-217. doi: 10.1016/j.eimc.2020.08.013. Epub 2020 Sep 9.
2
Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.蓝天研究对于终结结核病大流行以及推进个性化医疗方法以整体管理呼吸道感染至关重要。
Int J Infect Dis. 2022 Nov;124 Suppl 1:S69-S74. doi: 10.1016/j.ijid.2022.03.012. Epub 2022 Mar 14.
3
Post translational modifications in tuberculosis: ubiquitination paradox.
结核中的翻译后修饰：泛素化悖论。
Autophagy. 2021 Mar;17(3):814-817. doi: 10.1080/15548627.2020.1850009. Epub 2020 Nov 24.
4
Transient Transfection of the Respiratory Epithelium with Gamma Interferon for Host-Directed Therapy in Pulmonary Tuberculosis.用γ干扰素对呼吸道上皮进行瞬时转染用于肺结核的宿主导向治疗。
Mol Ther Nucleic Acids. 2020 Dec 4;22:1121-1128. doi: 10.1016/j.omtn.2020.10.023. Epub 2020 Oct 22.
5
Concerns about COVID-19 and tuberculosis in Brazil: Social and public health impacts.巴西对新冠病毒和结核病的担忧：社会及公共卫生影响
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Apr;39(4):216-217. doi: 10.1016/j.eimc.2020.08.013. Epub 2020 Sep 9.
6
Advantages and Challenges of Tailored Regimens for Drug-Resistant Tuberculosis: A StopTB Italia Look into the Future.耐多药结核病个体化治疗方案的优势与挑战：意大利终止结核病组织展望未来
Infect Drug Resist. 2020 Aug 11;13:2795-2800. doi: 10.2147/IDR.S257480. eCollection 2020.
7
COVID-19 and malaria: A symptom screening challenge for malaria endemic countries.新冠病毒肺炎与疟疾：疟疾流行国家面临的症状筛查挑战
Int J Infect Dis. 2020 May;94:151-153. doi: 10.1016/j.ijid.2020.04.007. Epub 2020 Apr 27.